InVivo acquires Bioline from Syngenta

InVivo has signed an agreement to acquire, through its holding company InVivo AgroSciences, Bioline, a subsidiary of Syngenta specialized in the production and marketing of biological control agents, and in particular macro-organisms active against insects pests in fruits, vegetable and flower crops. By joining forces, Bioline and Biotop, a longstanding InVivo subsidiary working in biological pest control, will become a global player in a high-potential and fast-growing market.

The growth of this USD 2.8 billion market is estimated at 10% a year for the coming ten years.

Bioline has two production sites in the UK and USA. The company is highly present in the macro-organisms market and more specifically in mites in northern Europe used against predatory insects in greenhouse crops. Biotop has a bioplant in the Drôme department in France, specialised notably in the production of ephestia eggs (used for raising auxiliaries) and trichogramma (micro-wasps that fight against corn borers).

Commenting, Thierry Blandinières, CEO of the InVivo group, said: “The acquisition of Bioline demonstrates InVivo’s strategic ambition to invest in high-potential solutions that will enable agriculture to produce more in response to the world’s demographic issues while ensuring the greatest respect for natural balances.”

Alexander Tokarz, Head of Global Crops and Assets at Syngenta said: “Bioline is a strongly performing business with good potential for further growth. Due to its highly specialized nature, we are convinced that Bioline’s potential will be better realized in combination with InVivo, who are already well positioned in this market. Syngenta remains fully committed to the broader field of biological solutions complementing our innovative crop protection and traits portfolio with enhanced spectrum and differentiated modes of actions.”

For more information:

www.invivo-group.com